Clinical Study of therapeutic effect of Yuyinyanggan decoction on patients of primary biliary cholangitis with 25-OH-D by LC-MS/MS

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037243

Enrollment

Unknown

Registered

2020-08-27

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary biliary cholangitis

Interventions

experimental group:Yuyinyanggan decoction+Ursodeoxycholic Acid Capsules

control group:placebo of Yuyinyanggan decoction +Ursodeoxycholic Acid Capsules

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Volunteer to be as the subject; 2. in line with diagnostic criteria of PBC; 3. in line with Chinese medicine syndrome of deficiency of liver-yin and kidney-yin; 4. To be aged 30 to 65 years old.

Exclusion criteria

Exclusion criteria: 1. autoimmune hepatitis and primary sclerosing cholangitis overlap syndrome; 2. with hepatic encephalopathy or Upper gastrointestinal bleeding; 3. complication with other chronic liver diseases and liver cancer; 4. take glucocorticoid.

Design outcomes

Primary

Measure	Time frame
25-OH-vit D;liver function;	—

Countries

China

Contacts

Public ContactFan Xingliang

Shanghai Municipal Hospital of Traditional Chinese Medicine

1212fxl@163.com+86 15221787677

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026